Baxter International Inc's ROI from its second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Baxter International Inc's ROI in the second quarter of 2026?
Baxter International Inc had a negative return on investment (ROI) of -6.38%, due to the net loss of $-1 billion, during the twelve months ending in the second quarter of 2026.

Within the Healthcare sector 230 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the first quarter of 2026 from 2607 to 2959.

Definition and Formula of Return on Investment

Select the Comparisons :

None ▼

Select the Ratio:

Return on Investment ROI▼

None ▼

Return on Investment ROI▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Investment	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter
Y / Y Investment Change TTM	-12.02 %	-12.05 %	-13.98 %	-16.21 %	-16.25 %
Y / Y Net Income Change TTM	-	-	-	-	-
Investment (TTM) in Millions	16,200	16,126	17,058	17,265	18,080
Return On Investment (TTM)	-6.38 %	-6.41 %	-5.45 %	-1.87 %	-0.79 %
BAX's Overall Ranking	# 2959	# 2607	# 676	# 2549	# 2302
Seq. Investment Change TTM	-2.74 %	-2.38 %	-3.14 %	-4.33 %	-2.78 %
Seq. Net Income Change TTM	-	-	-	-	-
Net Income (TTM) in Millions	-1,063	-1,098	-957	-339	-149

BAX Company Profile >> Back to BAX Roi Comparisons >> See Annual BAX Return On Investment

Return On Investment BAX's Ranking
Within:	No.
Industry	# 75
Sector	# 231
Overall	# 2959

Return On Investment Statistics
High	Average	Low
38.37 %	10.08 %	-10.21 %
(Dec 31 2016)		(Jun 30 2023)

Financial Statements
Baxter International Inc's II. Quarter Investments	$ 16,200 Millions	BAX's Balance sheet
Baxter International Inc's II. Quarter Income	$ 126 Millions	Quarterly BAX's Income Statement
BAX's Income by Division		See BAX's Income by Division

BAX Annual Return On Investment	(Dec 31 2025) 2025	(Dec 31 2024) 2024	(Dec 31 2023) 2023	(Dec 31 2022) 2022	(Dec 31 2021) 2021
Total Investments in Millions	17,058	19,331	21,839	23,604	29,329
Y / Y Investment Growth	-11.76 %	-11.48 %	-7.48 %	-19.52 %	75.38 %
Net Income in Millions	-957	-638	2,663	-2,421	1,295
Y / Y Net Income Growth	-	-	-	-	16.67 %
Annual Return On Investment	-5.61 %	-3.3 %	12.19 %	-10.26 %	4.42 %

Annual Roi Comment

Definition and Formula of Return on Investment

Other ROI Ratios
Medical Equipment & Supplies Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
BAX's Roi Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for BAX's Competitors
Subscribers only: Roi for Baxter International Inc's Suppliers
Subscribers only: Return On Investment for BAX's Customers

Other Ratios
BAX's Roa	BAX's Inventory Turnover Ratio	BAX's Growth Rates	BAX's Dividend Statistics
	BAX's Profitability Ratios	BAX's Asset Turnover Ratio	BAX's Dividend Growth
BAX's Roe	BAX's Valuation Ratios	BAX's Financial Strength Ratios	BAX's Dividend Payout Ratio

Companies with similar Return On Investment at Jun 30 2026, within Healthcare Sector

ROI

Date modified: 2026-09-13T23:20:18+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.